doc2012 national physician fee schedule relative value units
download 
Denúncia Transcrição
2012 national physician fee schedule relative value units
1211_RVUcharts.qxd:2008 12/1/11 4:26 PM Page 49 4 / CAP TODAY 2012 physician fee schedule RVUs CPT/ HCPCS 38220 38221 38230 80500 80502 83020 83912 84165 84166 84181 84182 85060 85097 85390 85396 85576 86077 86078 86079 86255 86256 86320 86325 86327 86334 86335 86386 87164 87207 87389 88104 88104 88104 88106 88106 88106 88108 88108 88108 88112 88112 88112 88120 88120 88120 88121 88121 88121 88125 88125 88125 88141 88160 88160 88160 88161 88161 88161 88162 88162 88162 88172 88172 88172 88173 88173 88173 88177 88177 88177 88182 88182 88182 88184 88185 88187 88188 88189 88291 88300 88300 88300 88302 88302 88302 88304 88304 88304 88305 88305 88305 88307 88307 88307 88309 88309 88309 88311 88311 Page 48 Modifier continued from page 3 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 Description Bone marrow aspiration Bone marrow biopsy Bone marrow harvest allogen Lab pathology consultation Lab pathology consultation Hemoglobin electrophoresis Genetic examination Protein e-phoresis serum Protein e-phoresis/urine/csf Western blot test Protein western blot test Blood smear interpretation Bone marrow interpretation Fibrinolysins screen Clotting assay whole blood Blood platelet aggregation Physician blood bank service Physician blood bank service Physician blood bank service Fluorescent antibody screen Fluorescent antibody titer Serum immunoelectrophoresis Other immunoelectrophoresis Immunoelectrophoresis assay Immunofix e-phoresis serum Immunfix e-phoresis/urine/csf Nuclear matrix protein 22 Dark field examination Smear special stain HIV-1 ag w/HIV-1 & HIV-2 ab Cytopath fl nongyn smears Cytopath fl nongyn smears Cytopath fl nongyn smears Cytopath fl nongyn filter Cytopath fl nongyn filter Cytopath fl nongyn filter Cytopath concentrate tech Cytopath concentrate tech Cytopath concentrate tech Cytopath cell enhance tech Cytopath cell enhance tech Cytopath cell enhance tech Cytp urine 3–5 probes ea spec Cytp urine 3–5 probes ea spec Cytp urine 3–5 probes ea spec Cytp urine 3–5 probes cmptr Cytp urine 3–5 probes cmptr Cytp urine 3–5 probes cmptr Forensic cytopathology Forensic cytopathology Forensic cytopathology Cytopath c/v interpret Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytopath smear other source Cytp dx eval fna 1st ea site Cytp dx eval fna 1st ea site Cytp dx eval fna 1st ea site Cytopath eval fna report Cytopath eval fna report Cytopath eval fna report Cytp fna eval ea addl Cytp fna eval ea addl Cytp fna eval ea addl Cell marker study Cell marker study Cell marker study Flow cytometry/ tc 1 marker Flow cytometry/tc add-on Flow cytometry/read 2–8 Flow cytometry/read 9–15 Flow cytometry/read 16 & > Cyto/molecular report Surgical path gross Surgical path gross Surgical path gross Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Tissue exam by pathologist Decalcify tissue Decalcify tissue Status code Work RVU Transitioned Non- Facility facility PE PE RVU RVU A A A A A A A A A A A A A A A A A A A A A A A A A A X A A X A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A 1.08 1.37 3.09 0.37 1.33 0.37 0.37 0.37 0.37 0.37 0.37 0.45 0.94 0.37 0.37 0.37 0.94 0.94 0.94 0.37 0.37 0.37 0.37 0.42 0.37 0.37 0.00 0.37 0.37 0.00 0.56 0.56 0.00 0.37 0.37 0.00 0.44 0.44 0.00 1.18 1.18 0.00 1.20 1.20 0.00 1.00 1.00 0.00 0.26 0.26 0.00 0.42 0.50 0.50 0.00 0.50 0.50 0.00 0.76 0.76 0.00 0.69 0.69 0.00 1.39 1.39 0.00 0.42 0.42 0.00 0.77 0.77 0.00 0.00 0.00 1.36 1.69 2.23 0.52 0.08 0.08 0.00 0.13 0.13 0.00 0.22 0.22 0.00 0.75 0.75 0.00 1.59 1.59 0.00 2.80 2.80 0.00 0.24 0.24 3.50 3.42 NA 0.18 0.45 0.17 0.14 0.16 0.16 0.16 0.13 0.20 1.46 0.17 NA 0.17 0.51 0.52 0.52 0.17 0.16 0.16 0.16 0.19 0.16 0.16 0.00 0.16 0.17 0.00 1.41 0.23 1.18 1.75 0.17 1.58 1.62 0.18 1.44 1.78 0.43 1.35 12.65 0.29 12.36 10.95 0.32 10.63 0.37 0.11 0.26 0.41 1.12 0.20 0.92 1.16 0.19 0.97 1.72 0.32 1.40 0.84 0.29 0.55 2.64 0.56 2.08 0.37 0.18 0.19 2.17 0.20 1.97 2.42 1.46 0.52 0.67 0.66 0.31 0.73 0.04 0.69 1.49 0.05 1.44 1.58 0.09 1.49 2.34 0.30 2.04 5.25 0.69 4.56 7.53 1.20 6.33 0.30 0.10 0.59 0.74 1.66 0.12 0.40 0.17 0.14 0.16 0.16 0.16 0.13 0.20 0.37 0.17 0.16 0.17 0.41 0.42 0.42 0.17 0.16 0.16 0.16 0.19 0.16 0.16 0.00 0.16 0.17 0.00 NA 0.23 NA NA 0.17 NA NA 0.18 NA NA 0.43 NA NA 0.29 NA NA 0.32 NA NA 0.11 NA 0.41 NA 0.20 NA NA 0.19 NA NA 0.32 NA NA 0.29 NA NA 0.56 NA NA 0.18 NA NA 0.20 NA NA NA 0.52 0.67 0.66 0.31 NA 0.04 NA NA 0.05 NA NA 0.09 NA NA 0.30 NA NA 0.69 NA NA 1.20 NA NA 0.10 Malpractice RVU 0.11 0.08 0.70 0.03 0.07 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.05 0.03 0.03 0.03 0.05 0.05 0.05 0.03 0.01 0.01 0.01 0.03 0.03 0.03 0.00 0.03 0.03 0.00 0.02 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.05 0.04 0.01 0.06 0.03 0.03 0.04 0.03 0.01 0.02 0.01 0.01 0.03 0.02 0.01 0.01 0.02 0.01 0.01 0.04 0.03 0.01 0.02 0.01 0.01 0.05 0.04 0.01 0.02 0.01 0.01 0.06 0.03 0.03 0.01 0.01 0.08 0.10 0.12 0.03 0.02 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.05 0.04 0.01 0.11 0.08 0.03 0.02 0.01 Transitioned Nonfacility Facility total total 4.69 4.87 NA 0.58 1.85 0.57 0.54 0.56 0.56 0.56 0.53 0.68 2.45 0.57 NA 0.57 1.50 1.51 1.51 0.57 0.54 0.54 0.54 0.64 0.56 0.56 0.00 0.56 0.57 0.00 1.99 0.80 1.19 2.14 0.55 1.59 2.08 0.63 1.45 3.01 1.65 1.36 13.91 1.52 12.39 11.99 1.35 10.64 0.65 0.38 0.27 0.86 1.64 0.71 0.93 1.68 0.70 0.98 2.52 1.11 1.41 1.55 0.99 0.56 4.08 1.99 2.09 0.81 0.61 0.20 3.00 1.00 2.00 2.43 1.47 1.96 2.46 3.01 0.86 0.83 0.13 0.70 1.64 0.19 1.45 1.82 0.32 1.50 3.11 1.06 2.05 6.89 2.32 4.57 10.44 4.08 6.36 0.56 0.35 1.78 2.19 5.45 0.52 1.8 0.57 0.54 0.56 0.56 0.56 0.53 0.68 1.36 0.57 0.56 0.57 1.4 1.41 1.41 0.57 0.54 0.54 0.54 0.64 0.56 0.56 0 0.56 0.57 0 NA 0.8 NA NA 0.55 NA NA 0.63 NA NA 1.65 NA NA 1.52 NA NA 1.35 NA NA 0.38 NA 0.86 NA 0.71 NA NA 0.7 NA NA 1.11 NA NA 0.99 NA NA 1.99 NA NA 0.61 NA NA 1 NA NA NA 1.96 2.46 3.01 0.86 NA 0.13 NA NA 0.19 NA NA 0.32 NA NA 1.06 NA NA 2.32 NA NA 4.08 NA NA 0.35 CPT/ HCPCS 88311 88312 88312 88312 88313 88313 88313 88314 88314 88314 88319 88319 88319 88321 88323 88323 88323 88325 88329 88331 88331 88331 88332 88332 88332 88333 88333 88333 88334 88334 88334 88342 88342 88342 88346 88346 88346 88347 88347 88347 88348 88348 88348 88349 88349 88349 88355 88355 88355 88356 88356 88356 88358 88358 88358 88360 88360 88360 88361 88361 88361 88362 88362 88362 88363 88365 88365 88365 88367 88367 88367 88368 88368 88368 88371 88372 88380 88380 88380 88381 88381 88381 88384 88384 88384 88385 88385 88385 88386 88386 88386 88387 88387 88387 88388 88388 88388 89060 Modifier December 2011 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 26 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 Description Status code Decalcify tissue Special stains group 1 Special stains group 1 Special stains group 1 Special stains group 2 Special stains group 2 Special stains group 2 Histochemical stains add-on Histochemical stains add-on Histochemical stains add-on Enzyme histochemistry Enzyme histochemistry Enzyme histochemistry Microslide consultation Microslide consultation Microslide consultation Microslide consultation Comprehensive review of data Path consult introp Path consult intraop 1 bloc Path consult intraop 1 bloc Path consult intraop 1 bloc Path consult intraop addl Path consult intraop addl Path consult intraop addl Intraop cyto path consult 1 Intraop cyto path consult 1 Intraop cyto path consult 1 Intraop cyto path consult 2 Intraop cyto path consult 2 Intraop cyto path consult 2 Immunohistochemistry Immunohistochemistry Immunohistochemistry Immunofluorescent study Immunofluorescent study Immunofluorescent study Immunofluorescent study Immunofluorescent study Immunofluorescent study Electron microscopy Electron microscopy Electron microscopy Scanning electron microscopy Scanning electron microscopy Scanning electron microscopy Analysis skeletal muscle Analysis skeletal muscle Analysis skeletal muscle Analysis nerve Analysis nerve Analysis nerve Analysis tumor Analysis tumor Analysis tumor Tumor immunohistochem/manual Tumor immunohistochem/manual Tumor immunohistochem/manual Tumor immunohistochem/comput Tumor immunohistochem/comput Tumor immunohistochem/comput Nerve teasing preparations Nerve teasing preparations Nerve teasing preparations Xm archive tissue molec anal In situ hybridization (fish) In situ hybridization (fish) In situ hybridization (fish) In situ hybridization auto In situ hybridization auto In situ hybridization auto In situ hybridization manual In situ hybridization manual In situ hybridization manual Protein western blot tissue Protein analysis w/probe Microdissection laser Microdissection laser Microdissection laser Microdissection manual Microdissection manual Microdissection manual Eval molecular probes 11–50 Eval molecular probes 11–50 Eval molecular probes 11–50 Eval molecul probes 51–250 Eval molecul probes 51–250 Eval molecul probes 51–250 Eval molecul probes 251–500 Eval molecul probes 251–500 Eval molecul probes 251–500 Tiss exam molecular study Tiss exam molecular study Tiss exam molecular study Tiss ex molecul study add-on Tiss ex molecul study add-on Tiss ex molecul study add-on Exam synovial fluid crystals A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A C C C A A A A A A A A A A A A A Work RVU Transitioned Non- Facility facility PE PE RVU RVU 0.00 0.54 0.54 0.00 0.24 0.24 0.00 0.45 0.45 0.00 0.53 0.53 0.00 1.63 1.83 1.83 0.00 2.50 0.67 1.19 1.19 0.00 0.59 0.59 0.00 1.20 1.20 0.00 0.73 0.73 0.00 0.85 0.85 0.00 0.86 0.86 0.00 0.86 0.86 0.00 1.51 1.51 0.00 0.76 0.76 0.00 1.85 1.85 0.00 3.02 3.02 0.00 0.95 0.95 0.00 1.10 1.10 0.00 1.18 1.18 0.00 2.17 2.17 0.00 0.37 1.20 1.20 0.00 1.30 1.30 0.00 1.40 1.40 0.00 0.37 0.37 1.56 1.56 0.00 1.18 1.18 0.00 0.00 0.00 0.00 1.50 1.50 0.00 1.88 1.88 0.00 0.62 0.62 0.00 0.45 0.45 0.00 0.37 0.20 2.19 0.21 1.98 1.67 0.09 1.58 1.88 0.18 1.70 2.31 0.21 2.10 0.91 2.15 0.52 1.63 3.17 0.85 1.51 0.53 0.98 0.59 0.26 0.33 1.61 0.52 1.09 1.00 0.32 0.68 2.21 0.32 1.89 2.16 0.34 1.82 1.29 0.21 1.08 19.05 0.58 18.47 10.71 0.34 10.37 3.79 0.51 3.28 4.81 0.57 4.24 1.23 0.25 0.98 2.40 0.37 2.03 3.22 0.42 2.80 6.57 0.88 5.69 0.64 3.63 0.43 3.20 6.40 0.42 5.98 5.05 0.36 4.69 0.15 0.08 3.76 0.59 3.17 3.52 0.28 3.24 0.00 0.00 0.00 14.60 0.29 14.31 16.35 0.52 15.83 0.38 0.20 0.18 0.43 0.20 0.23 0.16 NA NA 0.21 NA NA 0.09 NA NA 0.18 NA NA 0.21 NA 0.64 NA 0.52 NA 1.04 0.30 NA 0.53 NA NA 0.26 NA NA 0.52 NA NA 0.32 NA NA 0.32 NA NA 0.34 NA NA 0.21 NA NA 0.58 NA NA 0.34 NA NA 0.51 NA NA 0.57 NA NA 0.25 NA NA 0.37 NA NA 0.42 NA NA 0.88 NA 0.06 NA 0.43 NA NA 0.42 NA NA 0.36 NA 0.15 0.08 NA 0.59 NA NA 0.28 NA NA 0.00 NA NA 0.29 NA NA 0.52 NA NA 0.20 NA NA 0.20 NA 0.16 Malpractice RVU 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.04 0.03 0.01 0.10 0.05 0.04 0.01 0.12 0.04 0.02 0.01 0.01 0.02 0.01 0.01 0.05 0.04 0.01 0.04 0.03 0.01 0.04 0.03 0.01 0.02 0.01 0.01 0.02 0.01 0.01 0.12 0.04 0.08 0.07 0.03 0.04 0.06 0.05 0.01 0.18 0.14 0.04 0.04 0.03 0.01 0.04 0.03 0.01 0.05 0.04 0.01 0.14 0.10 0.04 0.03 0.04 0.03 0.01 0.06 0.05 0.01 0.05 0.04 0.01 0.03 0.03 0.05 0.04 0.01 0.04 0.03 0.01 0.00 0.00 0.00 0.07 0.04 0.03 0.08 0.05 0.03 0.02 0.01 0.01 0.02 0.01 0.01 0.03 Transitioned Nonfacility Facility total total 0.21 2.75 0.76 1.99 1.93 0.34 1.59 2.35 0.64 1.71 2.88 0.77 2.11 2.64 4.03 2.39 1.64 5.79 1.56 2.72 1.73 0.99 1.20 0.86 0.34 2.86 1.76 1.10 1.77 1.08 0.69 3.10 1.20 1.90 3.04 1.21 1.83 2.17 1.08 1.09 20.68 2.13 18.55 11.54 1.13 10.41 5.70 2.41 3.29 8.01 3.73 4.28 2.22 1.23 0.99 3.54 1.50 2.04 4.45 1.64 2.81 8.88 3.15 5.73 1.04 4.87 1.66 3.21 7.76 1.77 5.99 6.50 1.80 4.70 0.55 0.48 5.37 2.19 3.18 4.74 1.49 3.25 0.00 0.00 0.00 16.17 1.83 14.34 18.31 2.45 15.86 1.02 0.83 0.19 0.90 0.66 0.24 0.56 NA NA 0.76 NA NA 0.34 NA NA 0.64 NA NA 0.77 NA 2.37 NA 2.39 NA 3.66 1.01 NA 1.73 NA NA 0.86 NA NA 1.76 NA NA 1.08 NA NA 1.2 NA NA 1.21 NA NA 1.08 NA NA 2.13 NA NA 1.13 NA NA 2.41 NA NA 3.73 NA NA 1.23 NA NA 1.5 NA NA 1.64 NA NA 3.15 NA 0.46 NA 1.66 NA NA 1.77 NA NA 1.8 NA 0.55 0.48 NA 2.19 NA NA 1.49 NA NA 0 NA NA 1.83 NA NA 2.45 NA NA 0.83 NA NA 0.66 NA 0.56 CPT codes and descriptions only are copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. December 2011 page 4 January 2011 Page 49
Documentos relacionados
ATP-Binding Cassette Systems of Brucella
number of predicted functional ABC systems encoded by the
genomes of the Brucella strains is similar but does show some
variability (BM = 79, BS = 72, BA = 64, BC = 74, BO = 59).
Our evaluation of ...
Order_form_q7
See FIGURE 7 Measure from front of back post to front edge of seat sling. Seat sling is 1"
shorter than depth ordered, but actual seat depth will remain the same as ordered.
CBSE RESULTS-MARCH-2014.txt - Kendriya Vidyalaya Guntakal
101 A2 B2 B1 08 122 A2 A2 A2 09 041 B1 B2 B1**08 QUAL 8.2 A1
03/12/1998 M114/06100/0017 086 B1 B2 B1 08 087 B1 C1 B1**08
511 A 512 A 513 A 514 A 515 A 521 A 522 A 523 A 525 A 532 A 535 A 541 A 542 ...
www.ifti.co.nr
101 B1 C1 B2 07 303 A2 B1 A2 09 041 C1 E2 C2**05
QUAL 6.2
086 B1 E1 C2 05 087 C1 E1 C2**05
511 A 512 A 513 A 514 A 515 A 521 A 522 A 523 A 525 A 531 B 532 A 541 A 548 A
8103376 SAMREEN BEGUM ASGARA...